NEPHROS, INC. Payments of Stock Issuance Costs
NEPHROS, INC. (NEPH) reported Payments of Stock Issuance Costs of $1.05 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-03-03
- NEPHROS, INC. payments of stock issuance costs for the quarter ending 2020-12-31 was $319.00K.
- NEPHROS, INC. payments of stock issuance costs for the quarter ending 2020-09-30 was $0.00.
- NEPHROS, INC. payments of stock issuance costs for the quarter ending 2020-06-30 was $729.00K, a 9012.50% increase year-over-year.
- NEPHROS, INC. payments of stock issuance costs for the quarter ending 2020-03-31 was $729.00K.
- NEPHROS, INC. payments of stock issuance costs for fiscal 2020 was $1.05M, a 13000.00% increase from fiscal 2019.
- NEPHROS, INC. payments of stock issuance costs for fiscal 2019 was $8.00K, a 57.89% decline from fiscal 2018.
- NEPHROS, INC. payments of stock issuance costs for fiscal 2018 was $19.00K, a 87.50% decline from fiscal 2017.
- NEPHROS, INC. payments of stock issuance costs for fiscal 2017 was $152.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $319.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.05M derived: sum of 3 quarters · filed 2022-03-03 | $1.05M 10-K · filed 2022-03-03 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $729.00K derived: sum of 2 quarters · filed 2021-11-04 | $729.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $729.00K 10-Q · filed 2020-08-05 | $729.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $729.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $8.00K 10-K · filed 2021-03-01 | |||
| 2019-06-30 | $8.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $19.00K derived: sum of 3 quarters · filed 2020-02-27 | $19.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $19.00K derived: sum of 2 quarters · filed 2019-11-06 | $19.00K 10-Q · filed 2018-11-08 | $19.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $19.00K 10-Q · filed 2019-11-06 | $19.00K 10-Q · filed 2018-08-08 | $19.00K derived: sum of 3 quarters · filed 2019-11-06 | $19.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $8.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $8.00K derived: sum of 3 quarters · filed 2019-03-12 | $152.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $8.00K derived: sum of 2 quarters · filed 2018-11-08 | $152.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $152.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $144.00K 10-Q · filed 2018-05-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $24.00K 10-K · filed 2016-03-30 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $24.00K 10-Q · filed 2015-11-10 | ||
| 2015-06-30 | $24.00K 10-Q · filed 2015-08-10 | |||
| 2014-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $148.00K derived: sum of 2 quarters · filed 2015-04-15 | $151.00K derived: sum of 3 quarters · filed 2015-04-15 | $276.00K 10-K · filed 2015-04-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $3.00K derived: sum of 2 quarters · filed 2014-11-13 | $128.00K 10-Q · filed 2014-11-13 | $128.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $128.00K 10-Q · filed 2014-08-14 | $128.00K derived: sum of 3 quarters · filed 2015-05-15 | $128.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-03-31 | $125.00K 10-Q · filed 2015-05-15 | $125.00K derived: sum of 2 quarters · filed 2015-05-15 | $125.00K derived: sum of 3 quarters · filed 2015-05-15 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $229.00K 10-K · filed 2015-04-15 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $229.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $229.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |